中文 | English
Return
Total: 1366 , 1/137
Show Home Prev Next End page: GO
Author:(Fen-fen ZHANG)

1.Study on the variation patterns of corneal biomechanical parameters and binocular symmetry in children of different genders aged 8 to 16 years

Mei LI ; Biao WANG ; Fen ZHANG ; Yuting ZHANG ; Ze PEI ; Ning LU ; Feng CHANG

International Eye Science 2026;26(3):483-488

2.Advancement of functional peptides: Promising candidates for antituberculosis therapeutics

Bojie LIN ; Siqi LIN ; Jiayi YANG ; Xuanyu YANG ; Shuhui WANG ; Yuting LIU ; Qianqian ZHANG ; Junfa XU ; Jiang PI ; Fen YANG

Science of Traditional Chinese Medicine 2026;4(1):24-32

3.Analysis of sarcopenia prevalence and related factors in community-dwelling older adults based on C-MSRA-7 combined with Ishii score

Lijun WANG ; Ping WU ; Haimin XU ; Kewen CHENG ; Fen RAO ; Miaomiao YAO ; Yu ZHANG

Chinese Journal of Clinical Medicine 2026;33(4):643-650

5.Development of a balance device for anti-toppling in application of warm needling.

Fen ZHANG ; Zhifang YAO ; Ying BI ; Lianghua CHEN

Chinese Acupuncture & Moxibustion 2025;45(11):1695-1698

7.NSUN2 promotes proliferation, migration, and invasion of gastric cancer cells by mediating m5C modification of ARMC9

Yue LI ; Dong CHEN ; Jin WANG ; Yi PENG ; Yuanqi ZHANG ; Fen YANG ; Xuejun WANG

Journal of China Pharmaceutical University 2025;56(5):583-591

8.Analysis on epidemiological characteristics of severe congenital heart disease in Chongqing city during 2007-2023

Fen WANG ; Guanghui YIN ; Jie ZHANG ; Miao FENG ; Jun LIU

Chongqing Medicine 2025;54(2):505-511

9.Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway.

Da-Lin SUN ; Zi-Yi GUO ; Wen-Yuan LIU ; Lin ZHANG ; Zi-Yuan ZHANG ; Ya-Ling HU ; Su-Fen LI ; Ming-Yu ZHANG ; Guang ZHANG ; Jin-Jing WANG ; Jing-Ai FANG

Chinese journal of integrative medicine 2025;31(5):422-433

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1366 , 1/137 Show Home Prev Next End page: GO